Increase in Prevalence of Diabetic Ketoacidosis at Diagnosis Among Youth With Type 1 Diabetes: The SEARCH for Diabetes in Youth Study
- PMID: 34099516
- PMCID: PMC8323183
- DOI: 10.2337/dc20-0389
Increase in Prevalence of Diabetic Ketoacidosis at Diagnosis Among Youth With Type 1 Diabetes: The SEARCH for Diabetes in Youth Study
Abstract
Objective: We previously reported a high (˜30%) but stable prevalence of diabetic ketoacidosis (DKA) at youth-onset diagnosis of type 1 diabetes (2002 and 2010). Given the changing demographics of youth-onset type 1 diabetes, we sought to evaluate temporal trends in the prevalence of DKA at diagnosis of type 1 diabetes from 2010 to 2016 among youth <20 years of age and evaluate whether any change observed was associated with changes in sociodemographic distribution of those recently diagnosed.
Research design and methods: We calculated prevalence of DKA within 1 month of type 1 diabetes diagnosis by year and evaluated trends over time (2010-2016) (n = 7,612 incident diabetes cases; mean [SD] age 10.1 [4.5] at diagnosis). To assess whether trends observed were attributable to the changing distribution of sociodemographic factors among youth with incident type 1 diabetes, we estimated an adjusted relative risk (RR) of DKA in relation to calendar year, adjusting for age, sex, race/ethnicity, income, education, health insurance status, language, season of diagnosis, and SEARCH for Diabetes in Youth Study site.
Results: DKA prevalence increased from 35.3% (95% CI 32.2, 38.4) in 2010 to 40.6% (95% CI 37.8, 43.4) in 2016 (P trend = 0.01). Adjustment for sociodemographic factors did not substantively change the observed trends. We observed a 2% annual increase in prevalence of DKA at or near diagnosis of type 1 diabetes (crude RR 1.02 [95% CI 1.01, 1.04] and adjusted RR 1.02 [95% CI 1.01, 1.04]; P = 0.01 for both).
Conclusions: Prevalence of DKA at or near type 1 diabetes diagnosis has increased from 2010 to 2016, following the high but stable prevalence observed from 2002 to 2010. This increase does not seem to be attributable to the changes in distribution of sociodemographic factors over time.
© 2021 by the American Diabetes Association.
Figures
References
-
- Desai D, Mehta D, Mathias P, Menon G, Schubart UK. Health care utilization and burden of diabetic ketoacidosis in the U.S. over the past decade: a nationwide analysis. Diabetes Care 2018;41:1631–1638 - PubMed
-
- Mays JA, Jackson KL, Derby TA, et al. . An evaluation of recurrent diabetic ketoacidosis, fragmentation of care, and mortality across Chicago, Illinois. Diabetes Care 2016;39:1671–1676 - PubMed
-
- Wolfsdorf JI, Allgrove J, Craig ME, et al. .; International Society for Pediatric and Adolescent Diabetes . ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes 2014;15(Suppl. 20):154–179 - PubMed
-
- Rewers A, Klingensmith G, Davis C, et al. . Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics 2008;121:e1258–e1266 - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- P30 DK057516/DK/NIDDK NIH HHS/United States
- UC4 DK108173/DK/NIDDK NIH HHS/United States
- U18 DP002710/DP/NCCDPHP CDC HHS/United States
- U18 DP006138/DP/NCCDPHP CDC HHS/United States
- U18DP006138/ACL/ACL HHS/United States
- U18 DP002714/DP/NCCDPHP CDC HHS/United States
- U18DP006133/ACL/ACL HHS/United States
- U01 DP000244/DP/NCCDPHP CDC HHS/United States
- UL1 TR000062/TR/NCATS NIH HHS/United States
- U18DP006131/ACL/ACL HHS/United States
- U18 DP002709/DP/NCCDPHP CDC HHS/United States
- UL1 TR001425/TR/NCATS NIH HHS/United States
- U18 DP006131/DP/NCCDPHP CDC HHS/United States
- U18 DP002708/DP/NCCDPHP CDC HHS/United States
- U01 DP000247/DP/NCCDPHP CDC HHS/United States
- U18DP006136/ACL/ACL HHS/United States
- UL1 TR000154/TR/NCATS NIH HHS/United States
- U18DP006134/ACL/ACL HHS/United States
- U01 DP000248/DP/NCCDPHP CDC HHS/United States
- U18 DP006136/DP/NCCDPHP CDC HHS/United States
- U18 DP006139/DP/NCCDPHP CDC HHS/United States
- UL1 TR000077/TR/NCATS NIH HHS/United States
- U18 DP006134/DP/NCCDPHP CDC HHS/United States
- R01 DK127208/DK/NIDDK NIH HHS/United States
- UL1 TR000423/TR/NCATS NIH HHS/United States
- EP-C-15-002/EPA/EPA/United States
- U01 DP000250/DP/NCCDPHP CDC HHS/United States
- U18DP006139/ACL/ACL HHS/United States
- U18 DP006133/DP/NCCDPHP CDC HHS/United States
- U01 DP000246/DP/NCCDPHP CDC HHS/United States
- UL1 TR001450/TR/NCATS NIH HHS/United States
- U01 DP000254/DP/NCCDPHP CDC HHS/United States
LinkOut - more resources
Full Text Sources
Medical
